Extremely preterm infants and risk of developing neurodevelopmental impairment later in childhood

A meta-analysis of previously reported studies by Gregory P. Moore, M.D., F.R.C.P.C., of The Ottawa Hospital, Ontario, Canada, and colleagues examined the rate of moderate to severe and severe neurodevelopmental impairment by gestational age in extremely preterm survivors followed up between ages 4 and 8 years, and determined whether there is a significant difference in impairment rates between the successive weeks of gestation of survivors.

The search of English-language publications found nine studies that met inclusion criteria of being published after 2004, a , follow-up rate of 65 percent or more, use of or classification for impairment, reporting by gestation, and meeting prespecified definitions of impairment. Researchers then extracted data using a structured data collection form and investigators were contacted for data clarification.

According to the study results, all extremely preterm infant survivors have a substantial likelihood of developing moderate to severe impairment. Wide confidence intervals at the lower gestations (eg. at 22 weeks, 43 percent) and high at the higher gestations (eg. at 25 weeks, 24 percent) limit the results. There was a statistically significant absolute decrease in moderate to severe impairment between each week of gestation.

"Knowledge of these data, including the limitations, should facilitate discussion during the shared decision-making process about care plans for these infants, particularly in centers without their own data," the study concludes.

More information: JAMA Pediatr. Published online August 26, 2013. DOI: 10.1001/jamapediatrics.2013.2395

add to favorites email to friend print save as pdf

Related Stories

Etanercept reduces work, activity impairment in RA

Jul 01, 2013

(HealthDay)—For patients with moderate-to-severe rheumatoid arthritis (RA), continued etanercept treatment is associated with reduced work and activity impairment, according to a study published online ...

Recommended for you

Survival of very premature infants is improving in France

Jan 29, 2015

Since 2011, nearly 7,000 premature infants have been enrolled in the Inserm EPIPAGE 2 study. This study is aimed at assessing the survival of infants born between 22 and 34 weeks' gestation, and their subsequent ...

Donors pledge $7.5 bn to extend child vaccine drive

Jan 27, 2015

Countries and private donors have pledged $7.5 billion (6.6 billion euros) to help immunise 300 million more children in developing countries over the next five years, a major vaccine alliance announced Tuesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.